Oppenheimer Upgrades Bed Bath & Beyond To Outperform

Analysts at Oppenheimer upgraded

from Market Perform to Outperform. The price target for Bed Bath & Beyond has been raised from $69 to $85. Bed Bath & Beyond shares have jumped 19.12% over the past 52 weeks, while the S&P 500 index has gained 15.17% in the same period. Bed Bath & Beyond's shares rose 0.53% to $77.07 in pre-market trading.